ACCL vs NCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

ACCL

37.3
AI Score
VS
NCI Wins

NCI

41.0
AI Score

Investment Advisor Scores

ACCL

37score
Recommendation
SELL

NCI

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACCL NCI Winner
Revenue 4.85M 17.63M NCI
Net Income 1.02M 42,615 ACCL
Gross Margin 44.1% 36.9% ACCL
Net Margin 21.1% 0.2% ACCL
Operating Income 1.08M 231,904 ACCL
ROE 46.7% 0.6% ACCL
ROA 26.1% 0.3% ACCL
Total Assets 3.91M 14.86M NCI
Cash 2.45M 299,730 ACCL
Current Ratio 1.82 2.61 NCI
Free Cash Flow 1.51M 2.23M NCI

Relative Price Performance (Last 90 Days)

ACCL 1M: +37.7% · 3M: +97.3% NCI 1M: +10.9% · 3M: +44.3%

Current Technical Phase

ACCL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (29.1% over 20 days), RSI 79

RSI (14): 78.9 · Price: $2.92

NCI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (15.4% over 20 days), RSI 69

RSI (14): 68.8 · Price: $12.99

Fundamentals Snapshot

Metric ACCL NCI
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 73.0 155.1
Revenue (TTM)
Revenue Growth 0.0% -0.5%
Gross Margin 0.4% 0.4%
Operating Margin 0.0% 0.0%
EPS 0.04 0.08
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NCI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.